Exact Mass: 371.039

Exact Mass Matches: 371.039

Found 109 metabolites which its exact mass value is equals to given mass value 371.039, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tetraconazole

2-(2,4-Dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether

C13H11Cl2F4N3O (371.0215)


CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9343; ORIGINAL_PRECURSOR_SCAN_NO 9342 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9319; ORIGINAL_PRECURSOR_SCAN_NO 9317 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9334; ORIGINAL_PRECURSOR_SCAN_NO 9331 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9370; ORIGINAL_PRECURSOR_SCAN_NO 9366 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9361; ORIGINAL_PRECURSOR_SCAN_NO 9360 CONFIDENCE standard compound; INTERNAL_ID 1352; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9358; ORIGINAL_PRECURSOR_SCAN_NO 9356 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3723 D016573 - Agrochemicals D010575 - Pesticides

   

Sipatrigine

4-Amino-2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)pyrimidine

C15H16Cl3N5 (371.0471)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents

   

S-sulfinatoglutathione

glutathione S-sulfinate

C10H17N3O8S2 (371.0457)


   

Arotinolol

5-(2-((3-(tert-Butylamino)-2-hydroxypropyl)thio)thiazol-4-yl)thiophene-2-carboxamide

C15H21N3O2S3 (371.0796)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker[1]. Arotinolol also shows potency for inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites[2]. Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases[1].

   

Carboplatin

7,7-diamino-6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione

C6H12N2O4Pt (371.0445)


Carboplatin is only found in individuals that have used or taken this drug. It is an organoplatinum compound that possesses antineoplastic activity. [PubChem]Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound D000970 - Antineoplastic Agents

   

Salicyluric beta-D-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({2-[(2-hydroxyphenyl)formamido]acetyl}oxy)oxane-2-carboxylic acid

C15H17NO10 (371.0852)


Salicyluric beta-D-glucuronide, also known as 1-O-salicyluroyl-beta-D-glucuronate or 1-O-[N-(2-hydroxybenzoyl)glycyl]-beta-D-glucronate, is a member of the class of compounds known as O-glucuronides. O-glucuronides are glucuronides in which the aglycone is linked to the carbohydrate unit through an O-glycosidic bond.

   

N,N-Bis(2-chloroethyl)-N',N'-diphenylphosphoric triamide

N,N-Bis(2-chloroethyl)-N,N-diphenylphosphoric triamide

C16H20Cl2N3OP (371.0721)


   

Arotinolol

5-(2-{[3-(tert-butylamino)-2-hydroxypropyl]sulphanyl}-1,3-thiazol-4-yl)thiophene-2-carboxamide

C15H21N3O2S3 (371.0796)


   

PYR-41

Ethyl 4-{4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoic acid

C17H13N3O7 (371.0753)


   

Phosphatase

Disodium hexahydric acid 4-nitrophenyl phosphoric acid

C6H16NNa2O12P (371.0206)


Phosphatase, also known as 4-nitrophenylphosphate or dipotassium nitrophenylphosphate, is a member of the class of compounds known as phenyl phosphates. Phenyl phosphates are aromatic organooxygen compounds containing a phosphate group, which is O-esterified with a phenyl group. Phosphatase can be found in a number of food items such as french plantain, fenugreek, pineapple, and horseradish, which makes phosphatase a potential biomarker for the consumption of these food products. A phosphatase is an enzyme that uses water to cleave a phosphoric acid monoester into a phosphate ion and an alcohol. Because a phosphatase enzyme catalyzes the hydrolysis of its substrate, it is a subcategory of hydrolases. Phosphatase enzymes are essential to many biological functions, because phosphorylation (e.g. by protein kinases) and dephosphorylation (by phosphatases) serve diverse roles in cellular regulation and signaling. Whereas phosphatases remove phosphate groups from molecules, kinases catalyze the transfer of phosphate groups to molecules from ATP. Together, kinases and phosphatases direct a form of post-translational modification that is essential to the cells regulatory network. Phosphatase enzymes are not to be confused with phosphorylase enzymes, which catalyze the transfer of a phosphate group from hydrogen phosphate to an acceptor. Due to their prevalence in cellular regulation, phosphatases are an area of interest for pharmaceutical research .

   

Pluracidomycin C

Pluracidomycin C1

C10H13NO10S2 (370.9981)


   
   
   

N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide

N-(3-Cyano-1H-indol-5-yl)-3-[4-(trifluoromethoxy)phenyl]acrylamide

C19H12F3N3O2 (371.0882)


   
   
   

Antibiotic M 53B1

Antibiotic M 53B1

C14H17N3O7S (371.0787)


   
   

3-{3-[2-hydroxybut-3-en-1-yl]-1,2,4-thiadiazol-5-yl}-5,6-dihydrospiro[indoline-3,2-thiopyran]-2-one

3-{3-[2-hydroxybut-3-en-1-yl]-1,2,4-thiadiazol-5-yl}-5,6-dihydrospiro[indoline-3,2-thiopyran]-2-one

C18H17N3O2S2 (371.0762)


   
   

Tetraconazole

Pesticide6_Tetraconazole_C13H11Cl2F4N3O_1-[2-(2,4-Dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-1H-1,2,4-triazole

C13H11Cl2F4N3O (371.0215)


D016573 - Agrochemicals D010575 - Pesticides

   

Zalcitabine diphosphate

Zalcitabine diphosphate

C9H15N3O9P2 (371.0284)


   
   

Asn-Met-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C14H17N3O7S (371.0787)


   

Met-Asn-OH

(S)-5-amino-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)-5-oxopentanoic acid

C14H17N3O7S (371.0787)


   
   

(6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R-trans)-7-amino-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C12H13N5O5S2 (371.0358)


   

N,N,N,N-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronium hexafluorophosphate

N,N,N,N-Tetramethyl-S-(1-oxido-2-pyridyl)thiuronium hexafluorophosphate

C10H16F6N3OPS (371.0656)


   

2-N-BOC-3-(3-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(3-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C16H22BrNO4 (371.0732)


   

n-bsmoc-l-methionine

n-bsmoc-l-methionine

C15H17NO6S2 (371.0497)


   

4-Iodo-N,N-diphenylaniline

4-Iodo-N,N-diphenylaniline

C18H14IN (371.0171)


   

8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline

8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline

C18H14BrNO3 (371.0157)


   

3-Bromo-9-(1-naphthyl)-9H-carbazole

3-Bromo-9-(1-naphthyl)-9H-carbazole

C22H14BrN (371.031)


   

Benzyl (S)-3-(Boc-amino)-4-bromobutanoate

Benzyl (S)-3-(Boc-amino)-4-bromobutanoate

C16H22BrNO4 (371.0732)


   

2-N-BOC-3-(4-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(4-BROMO-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C16H22BrNO4 (371.0732)


   

Irsogladine Maleate

6-(2,5-Dichlorophenyl)-1,3,5-triazine-2,4-diamine maleate

C13H11Cl2N5O4 (371.0188)


D020011 - Protective Agents > D011837 - Radiation-Protective Agents D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

1-{4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]PHENYL}-1H-PYRROLE

1-{4-[3,5-DI(TRIFLUOROMETHYL)PHENOXY]PHENYL}-1H-PYRROLE

C18H11F6NO (371.0745)


   

TERT-BUTYL 4-((4-BROMOPHENYL)THIO)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 4-((4-BROMOPHENYL)THIO)PIPERIDINE-1-CARBOXYLATE

C16H22BrNO2S (371.0555)


   

(-)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane

(-)-2β-Carbomethoxy-3β-(4-iodophenyl)nortropane

C15H18INO2 (371.0382)


   

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONATE

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONATE

C16H22BrNO4 (371.0732)


   

1H-1,3,4-Benzotriazepine,2-(2-thienyl)-5-[4-(trifluoromethyl)phenyl]-(9CI)

1H-1,3,4-Benzotriazepine,2-(2-thienyl)-5-[4-(trifluoromethyl)phenyl]-(9CI)

C19H12F3N3S (371.0704)


   

6-BROMO-2-(4-ETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(4-ETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H14BrNO3 (371.0157)


   

4-((4-(4-BROMO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)MORPHOLINE

4-((4-(4-BROMO-1H-PYRAZOL-1-YL)PHENYL)SULFONYL)MORPHOLINE

C13H14BrN3O3S (370.9939)


   

METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONATE

METHYL 2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONATE

C16H22BrNO4 (371.0732)


   

4-Nitrophenyl phosphate disodium hexahydrate

4-Nitrophenyl phosphate disodium salt hexahydrate

C6H16NNa2O12P (371.0206)


   

1-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)oxy]pyrrolidine-2,5-dione,hexafluorophosphate

1-[(1,3,4-trimethyl-4,5-dihydroimidazol-1-ium-2-yl)oxy]pyrrolidine-2,5-dione,hexafluorophosphate

C10H16F6N3O3P (371.0833)


   

9-(2-Naphthyl)-3-bromocarbazole

9-(2-Naphthyl)-3-bromocarbazole

C22H14BrN (371.031)


   

O-Succinimidyl-1,3-dimethylpropyleneuronium hexafluorophosphate

O-Succinimidyl-1,3-dimethylpropyleneuronium hexafluorophosphate

C10H16N3O3.PF6 (371.0833)


   

2-Bromo-9-(2-naphthyl)-9H-carbazole

2-Bromo-9-(2-naphthyl)-9H-carbazole

C22H14BrN (371.031)


   

5-Bromo-4-chloro-3-indolyl caprylate

5-Bromo-4-chloro-3-indolyl caprylate

C16H19BrClNO2 (371.0288)


   

5-Bromo-6-chloro-1H-indol-3-yl octanoate

5-Bromo-6-chloro-1H-indol-3-yl octanoate

C16H19BrClNO2 (371.0288)


   

N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)butane-1-sulphonamide

N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-N-(2-hydroxyethyl)butane-1-sulphonamide

C8H10F9NO3S (371.0238)


   

5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole

5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole

C15H12ClF2N3O2S (371.0307)


   

N-(2-Benzoyl-4-chlorophenyl)-3,4-difluorobenzamide

N-(2-Benzoyl-4-chlorophenyl)-3,4-difluorobenzamide

C20H12ClF2NO2 (371.0525)


   

5-Bromo-3-(Pyrrolidin-1-Ylsulfonyl)-1h-Indole-2-Carboxamide

5-Bromo-3-(Pyrrolidin-1-Ylsulfonyl)-1h-Indole-2-Carboxamide

C13H14BrN3O3S (370.9939)


   

Batabulin

Batabulin

C13H7F6NO3S (371.0051)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

   

Denotivir

Denotivir

C18H14ClN3O2S (371.0495)


C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

5-Dimethylarsinoyladenosine

5-Dimethylarsinoyladenosine

C12H18AsN5O4 (371.0575)


   
   

8-Hydroxy-pipat

8-Hydroxy-pipat

C16H22INO (371.0746)


   

2-(3-Pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole

2-(3-Pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole

C18H17N3O2S2 (371.0762)


   

Remdesivir nucleoside monophosphate

Remdesivir nucleoside monophosphate

C12H14N5O7P (371.0631)


COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

N-[6-acetyl-3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide

N-[6-acetyl-3-(1,3-benzothiazol-2-yl)-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]acetamide

C18H17N3O2S2 (371.0762)


   

7-hydroxy-PIPAT

7-hydroxy-PIPAT

C16H22INO (371.0746)


   
   
   

N-[4-[[[[oxo(thiophen-2-yl)methyl]amino]-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

N-[4-[[[[oxo(thiophen-2-yl)methyl]amino]-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

C17H13N3O3S2 (371.0398)


   

3-{[(3-Fluoro-3-Methoxybiphenyl-4-Yl)amino]carbonyl}thiophene-2-Carboxylic Acid

3-{[(3-Fluoro-3-Methoxybiphenyl-4-Yl)amino]carbonyl}thiophene-2-Carboxylic Acid

C19H14FNO4S (371.0628)


   

N-(4-Acetylphenyl)-5-(5-chloro-2,4-dihydroxyphenyl)-1H-pyrazole-4-carboxamide

N-(4-Acetylphenyl)-5-(5-chloro-2,4-dihydroxyphenyl)-1H-pyrazole-4-carboxamide

C18H14ClN3O4 (371.0673)


   

2-(Cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

2-(Cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate

C16H21NO5S2 (371.0861)


   

Ferrous cysteine glycinate

Ferrous cysteine glycinate

C8H17FeN3O6S2 (370.9908)


   

Tyrosine-betaxanthin

Tyrosine-betaxanthin

C18H15N2O7-3 (371.0879)


   

[(2R,3S,4R,5S)-5-(4-amino-5-cyanopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,3S,4R,5S)-5-(4-amino-5-cyanopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C12H14N5O7P (371.0631)


   

Paraplatin

Carboplatin

C6H12N2O4Pt (371.0445)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XA - Platinum compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D000970 - Antineoplastic Agents

   

7-Benzoyl-3-chloroindolizine-1,2-dicarboxylic acid dimethyl ester

7-Benzoyl-3-chloroindolizine-1,2-dicarboxylic acid dimethyl ester

C19H14ClNO5 (371.056)


   

5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furamide

5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furamide

C18H14BrNO3 (371.0157)


   

2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine

2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine

C17H19Cl2NO2S (371.0513)


   

2-[(3,4-Dichlorophenyl)methylthio]-6-(3-pyridinyl)-3-pyridinecarbonitrile

2-[(3,4-Dichlorophenyl)methylthio]-6-(3-pyridinyl)-3-pyridinecarbonitrile

C18H11Cl2N3S (371.0051)


   

4-[5-Amino-3-methyl-4-[oxo-[3-(trifluoromethyl)phenyl]methyl]-2-thiophenyl]butanoic acid

4-[5-Amino-3-methyl-4-[oxo-[3-(trifluoromethyl)phenyl]methyl]-2-thiophenyl]butanoic acid

C17H16F3NO3S (371.0803)


   

1-(2-Methoxyethyl)-7-thiophen-2-yl-5-(trifluoromethyl)pyrido[2,3-d]pyrimidine-2,4-dione

1-(2-Methoxyethyl)-7-thiophen-2-yl-5-(trifluoromethyl)pyrido[2,3-d]pyrimidine-2,4-dione

C15H12F3N3O3S (371.0551)


   

3-(1,3-benzothiazol-2-ylsulfanyl)-N-[(E)-(4-methoxyphenyl)methylideneamino]propanamide

3-(1,3-benzothiazol-2-ylsulfanyl)-N-[(E)-(4-methoxyphenyl)methylideneamino]propanamide

C18H17N3O2S2 (371.0762)


   

4-[(1-Methyl-5-tetrazolyl)thio]-5-(4-nitrophenyl)thieno[2,3-d]pyrimidine

4-[(1-Methyl-5-tetrazolyl)thio]-5-(4-nitrophenyl)thieno[2,3-d]pyrimidine

C14H9N7O2S2 (371.0259)


   

ethyl 4-{(4E)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoate

ethyl 4-{(4E)-4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl}benzoate

C17H13N3O7 (371.0753)


   

(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C15H22BrN3O3 (371.0844)


   

N-(5-(3-Methoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-YL)-isonicotinamide

N-(5-(3-Methoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-YL)-isonicotinamide

C17H13N3O3S2 (371.0398)


   

glutathione S-sulfinate

glutathione S-sulfinate

C10H17N3O8S2 (371.0457)


   

BW619c89

Sipatrigine

C15H16Cl3N5 (371.0471)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D049990 - Membrane Transport Modulators D020011 - Protective Agents

   

Salicyluric beta-D-glucuronide

Salicyluric beta-D-glucuronide

C15H17NO10 (371.0852)


   

GS-441524 monophosphate

GS-441524 monophosphate

C12H14N5O7P (371.0631)


A C-nucleoside phosphate that is GS-441524 in which the 5-hydroxy group has been replaced by a phosphate group. In cells, GS-441524 monophosphate gets converted into the pharmacologically active triphosphate form (GS-443902).

   

AS1949490

AS1949490

C20H18ClNO2S (371.0747)


AS1949490 is a potent, orally active, selective SHIP2 phosphatase inhibitor with IC50 values of 0.34, 0.62, 13, >50, >50, and >50 μM for Mouse SHIP2, Human SHIP2, Human SHIP1, Human PTEN, Human synaptojanin, and Human myotubularin, respectively. AS1949490 increases the phosphorylation of Akt, glucose consumption and glucose uptake. AS1949490 activates intracellular insulin signalling pathways. AS1949490 can be used for research of diabetes[1][2].

   

Azemiglitazone

Azemiglitazone

C19H17NO5S (371.0827)


Azemiglitazone (MSDC-0602) is an orally active thiazolidinedione (TZD) -like molecule, which binds to PPARγ with low binding and activating affinity. Azemiglitazone inhibits mitochondrial pyruvate carrier (MPC), which inhibits Alzheimer’s disease and diminishes nonalcoholic steatohepatitis (NASH) caused liver injury[4][5].

   

Quinotolast sodium

Quinotolast sodium

C17H12N6NaO3 (371.0869)


Quinotolast sodium in the concentration range of 1-100 μg/mL inhibits histamine, LTC4 and PGD2 release in a concentration-dependent manner.

   

aristolochic acid iv

aristolochic acid iv

C18H13NO8 (371.0641)


   

5-hydroxy-3,4-bis(4-hydroxy-3-nitrophenyl)pyrrol-2-one

5-hydroxy-3,4-bis(4-hydroxy-3-nitrophenyl)pyrrol-2-one

C16H9N3O8 (371.039)


   

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid

2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid

C18H13NO8 (371.0641)


   

2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol

2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol

C12H18AsN5O4 (371.0575)


   

7,8-dimethoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid

NA

C18H13NO8 (371.0641)


{"Ingredient_id": "HBIN012987","Ingredient_name": "7,8-dimethoxy-3,4-methylenedioxy-10-nitro-1-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "NA","Ingredient_weight": "371.3","OB_score": "NA","CAS_id": "79185-74-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7476","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-methoxy-aristolochiacacid

NA

C18H13NO8 (371.0641)


{"Ingredient_id": "HBIN013335","Ingredient_name": "7-methoxy-aristolochiacacid","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC2=CC(=C3C(=CC4=C(C3=C2C=C1OC)OCO4)C(=O)O)[N+](=O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13836","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-methoxy-aristolochiac acid a

3,4-Methylenedioxy-7,8-dimethoxy-10-nitrophenanthrene-1-carboxylic acid; AC1NSY17; 7-methoxyaristolochic acid a; 79185-74-3; 8,9-dimethoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid

C18H13NO8 (371.0641)


{"Ingredient_id": "HBIN013336","Ingredient_name": "7-methoxy-aristolochiac acid a","Alias": "3,4-Methylenedioxy-7,8-dimethoxy-10-nitrophenanthrene-1-carboxylic acid; AC1NSY17; 7-methoxyaristolochic acid a; 79185-74-3; 8,9-dimethoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC=CC2=C1C(=C(C3=C2C4=C(C=C3C(=O)O)OCO4)[N+](=O)[O-])OC","Ingredient_weight": "371.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19335","TCMID_id": "31525","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "46233015","DrugBank_id": "NA"}

   

aristolochicacid d methyl ether

NA

C18H13NO8 (371.0641)


{"Ingredient_id": "HBIN016804","Ingredient_name": "aristolochicacid d methyl ether","Alias": "NA","Ingredient_formula": "C18H13NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1714","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid

(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}propanoic acid

C18H13NO8 (371.0641)


   

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol

(2r,3r,4s,5s)-2-(6-aminopurin-9-yl)-5-[(dimethylarsoryl)methyl]oxolane-3,4-diol

C12H18AsN5O4 (371.0575)